Evidence map›Paper›PMID 25918203›Full record

ArticleThe American journal of tropical medicine and hygiene2015

Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by sera from multigravid, malaria-exposed Malian women.

Mark A Travassos, Drissa Coulibaly, Jason A Bailey, Amadou Niangaly, Matthew Adams, Myaing M Nyunt, Amed Ouattara, Kirsten E Lyke, Matthew B Laurens, Jozelyn Pablo and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Mark A Travassos
Drissa Coulibaly
Jason A Bailey
Amadou Niangaly
Matthew Adams
Myaing M Nyunt
Amed Ouattara
Kirsten E Lyke
Matthew B Laurens
Jozelyn Pablo
Algis Jasinskas
Rie Nakajima
Andrea A Berry
Shannon Takala-Harrison
Abdoulaye K Kone
Bourema Kouriba
J Alexandra Rowe
Ogobara K Doumbo
Mahamadou A Thera
Miriam K Laufer
Philip L Felgner
Christopher V Plowe

Funding

EXPAND PARTICIPATION BY MINORITIES IN BIOMEDICAL SCIENCER25GM055036 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI SUMMERS, MICHAEL FINLEY · 1996 to 2021
$16.9M
TransmissionU19AI089686 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2010 to 2016
$9.9M
Safety, Immunogenicity and Efficacy of VaccineU19AI065683 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2005 to 2009
$4.7M
MALARIA RESEARCH TRAINING IN MALID43TW001589 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2000 to 2015
$2.8M
Protective biomarkers for the development of vaccines against malariaR44AI066791 · NIAID · IMMPORT THERAPEUTICS, INC. · PI FELGNER, PHILIP LOUIS · 2012 to 2014
$2.3M
Immuno-epidemiological epitope mapping of a blood stage malaria vaccine antigenR01AI093635 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI PLOWE, CHRISTOPHER V. · 2012 to 2015
$2.3M
Predicting naturally acquired humoral immunity against malariaR01AI095916 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI FELGNER, PHILIP LOUIS · 2012 to 2016
$2.1M
Genome-wide studies to identify markers of artemisinin-resistant malariaR01AI101713 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI HARRISON, SHANNON TAKALA · 2013 to 2016
$1.8M
FIC NIH HHS D43 TW001589FIC NIH HHS D43TW001589NIAID NIH HHS R01 AI093635NIAID NIH HHS R01AI093635NIAID NIH HHS R01 AI095916NIAID NIH HHS R01AI095916NIAID NIH HHS R01 AI101713NIAID NIH HHS R01AI101713NIAID NIH HHS R44 AI066791NIAID NIH HHS R44AI066791NIAID NIH HHS U19 AI065683NIAID NIH HHS U19AI065683NIAID NIH HHS U19 AI089686NIAID NIH HHS U19AI089686NIGMS NIH HHS R25 GM055036Wellcome Trust 084226Wellcome Trust 095831
6 · The paper itself

Abstract

The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family mediates parasite sequestration in small capillaries through tissue-specific cytoadherence. The best characterized of these proteins is VAR2CSA, which is expressed on the surface of infected erythrocytes that bind to chondroitin sulfate in the placental matrix. Antibodies to VAR2CSA prevent placental cytoadherence and protect against placental malaria. The size and complexity of the VAR2CSA protein pose challenges for vaccine development, but smaller constitutive domains may be suitable for subunit vaccine development. A protein microarray was printed to include five overlapping fragments of the 3D7 VAR2CSA extracellular region. Malian women with a history of at least one pregnancy had antibody recognition of four of these fragments and had stronger reactivity against the two distal fragments than did nulliparous women, children, and men from Mali, suggesting that the C-terminal extracellular VAR2CSA domains are a potential focus of protective immunity. With carefully chosen sera from longitudinal studies of pregnant women, this approach has the potential to identify seroreactive VAR2CSA domains associated with protective immunity against pregnancy-associated malaria.

Indexed as

AdultAntigens, ProtozoanChildChild, PreschoolCross ReactionsFemaleGravidityHumansInfantMalaria, FalciparumMaleMaliPlasmodium falciparumPregnancyPregnancy Complications, ParasiticProtein Array AnalysisAntigens, ProtozoanVAR2CSA protein, Plasmodium falciparum

Identifiers

PMID25918203
PMCPMC4458824
OpenAlexW2170619664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.